Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study

Int J Cancer. 2021 Aug 1;149(3):585-593. doi: 10.1002/ijc.33563. Epub 2021 Apr 2.

Abstract

The association between oophorectomy and risk of breast cancer in the general population is uncertain. The aim of our study was to determine the breast cancer rate in women from the general population after oophorectomy (performed before/after menopause), and whether this varies by use of hormone replacement therapy (HRT), hysterectomy, body mass index (BMI) and shift work. The study included 24 409 female nurses (aged ≥45 years) participating in the Danish Nurse Cohort. Nurses were followed from cohort entry until date of breast cancer, death, emigration or end of follow-up at 31 December 2018, whichever came first. Poisson regression with log-transformed person-years as the offset examined the association between oophorectomy and breast cancer (all ages and stratified by menopausal status at time of oophorectomy). The potential modifying effect of HRT use, hysterectomy, BMI and shift work on the associations was estimated. During 502 463 person-years of follow-up, 1975 (8.1%) nurses were diagnosed with breast cancer. Bilateral oophorectomy was associated with a reduced breast cancer rate compared to nurses with preserved ovaries, adjusted rate ratio (95% confidence interval): 0.79 (0.64; 0.99). Similar associations (magnitude and direction) were detected for unilateral oophorectomy and when stratifying according to menopausal status at time of oophorectomy, but without statistical significance. Unilateral and bilateral oophorectomy is associated with a reduced breast cancer rate in women from the general population. This association is not modified by use of HRT, hysterectomy, BMI or shift work.

Keywords: breast cancer; hormone replacement therapy; hysterectomy; oophorectomy; rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Body Mass Index
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / etiology
  • Breast Neoplasms / pathology
  • Case-Control Studies
  • Denmark / epidemiology
  • Female
  • Follow-Up Studies
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Hysterectomy / adverse effects*
  • Menopause*
  • Middle Aged
  • Ovariectomy / adverse effects*
  • Prognosis
  • Prospective Studies
  • Risk Factors